Does MOBOCERTINIB Cause Non-small cell lung cancer? 96 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Non-small cell lung cancer have been filed in association with MOBOCERTINIB. This represents 13.4% of all adverse event reports for MOBOCERTINIB.
96
Reports of Non-small cell lung cancer with MOBOCERTINIB
13.4%
of all MOBOCERTINIB reports
43
Deaths
21
Hospitalizations
How Dangerous Is Non-small cell lung cancer From MOBOCERTINIB?
Of the 96 reports, 43 (44.8%) resulted in death, 21 (21.9%) required hospitalization, and 1 (1.0%) were considered life-threatening.
Is Non-small cell lung cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOBOCERTINIB. However, 96 reports have been filed with the FAERS database.
What Other Side Effects Does MOBOCERTINIB Cause?
Diarrhoea (309)
Death (160)
Rash (106)
Nausea (85)
Decreased appetite (80)
Lung neoplasm malignant (74)
Vomiting (74)
Fatigue (66)
Asthenia (56)
Weight decreased (54)
What Other Drugs Cause Non-small cell lung cancer?
SOTORASIB (483)
CARBOPLATIN (431)
BRIGATINIB (370)
NIVOLUMAB (366)
PACLITAXEL (275)
IPILIMUMAB (273)
PEMETREXED (234)
CERITINIB (183)
CRIZOTINIB (178)
AMG-510 (134)
Which MOBOCERTINIB Alternatives Have Lower Non-small cell lung cancer Risk?
MOBOCERTINIB vs MOCLOBEMIDE
MOBOCERTINIB vs MODAFINIL
MOBOCERTINIB vs MOGAMULIZUMAB
MOBOCERTINIB vs MOGAMULIZUMAB-KPKC
MOBOCERTINIB vs MOLNUPIRAVIR